首頁 > 市場調查報告書 > 製藥

疫苗動物用醫藥

市場調查報告書

商品編碼

1789426

犬用疫苗疫苗類型、應用、給藥途徑、最終用戶和地區分類

Dogs Vaccines Market, By Type of Vaccine, By Application, By Route of Administration, By End User, By Geography

出版日期: 2025年07月09日 | 出版商:

Coherent Market Insights | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

犬用疫苗市場規模預計在 2025 年達到 22.1 億美元，預計到 2032 年將達到 35.2 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 6.8%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	22.1億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年	6.80%	2032年預測	35.2億美元

已開發國家寵物飼養業的發展導致寵物犬疫苗接種範圍擴大。美國動物醫院協會等組織對寵物年度疫苗接種的嚴格規定進一步推動了犬用疫苗的需求。此外，寵物醫療保健支出的增加以及飼主對預防保健意識的不斷增強，預計將在預測期內推動市場成長。然而，獸醫護理和疫苗生產的高成本可能會在未來幾年在一定程度上抑制市場成長。

市場動態

全球犬用疫苗市場是由全球寵物擁有量的成長所驅動的。寵物日益人性化以及寵物醫療保健支出的增加，大大促進了家庭寵物擁有。此外，要求每年為狗接種疫苗的嚴格規定正在創造對犬用疫苗的穩定需求。然而，疫苗生產和獸醫服務的高成本給市場參與企業帶來了重大挑戰。此外，某些地區缺乏標準的獸醫護理實踐，抑制了市場成長。然而，針對多種疾病的新型疫苗的持續研發正在創造新的機會。此外，主要企業透過社群媒體行銷宣傳活動提高知名度也為市場提供了成長前景。

本次調查的主要特點

本報告對全球犬用疫苗市場進行了詳細分析，並以 2024 年為基準年，提供了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%）。
它還揭示了各個領域的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，介紹了全球犬用疫苗市場的主要企業概況。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、最新策略、市場擴張和行銷策略做出明智的決策。
全球犬用疫苗市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
透過全球犬用疫苗市場分析中使用的各種策略矩陣，相關人員將更容易做出決策。

介紹
北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- 東南亞國協
- 其他亞太地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
非洲
- 南非
- 北非
- 中部非洲

第9章競爭態勢

Zoetis
Merck Animal Health
Boehringer Ingelheim
Elanco Animal Health
Bayer Animal Health
Ceva Sante Animale
Virbac
Vetoquinol
Heska Corporation
Neogen Corporation
IDEXX Laboratories
Merial（Sanofi）
Phibro Animal Health
Aratana Therapeutics
Kemin Industries

第 10 章分析師建議

機會
一致的機會地圖

第 11 章參考文獻與調查方法

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI7747

Dogs Vaccines Market is estimated to be valued at USD 2.21 Bn in 2025 and is expected to reach USD 3.52 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 2.21 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.80%	2032 Value Projection:	USD 3.52 Bn

Growing pet adoption across developed nations has increased the scope for vaccination of pet dogs. Stringent regulations regarding annual vaccination of pets by organizations such as American Animal Hospital Association has further augmented the demand for dog vaccines. Also, increasing pet healthcare expenditure and rising awareness among pet owners about preventive care are the key factors expected to drive the market growth during the forecast period. However, high costs associated with veterinary care and vaccine production may restrain the market growth to some extent over the next few years.

Market Dynamics

The global dog vaccines market is driven by increasing pet adoption worldwide. Growing humanization of pets and rising expenditure on pet healthcare have significantly boosted the adoption of pets across households. Moreover, stringent regulations mandating annual vaccination of dogs have created steady demand for dog vaccines. However, high costs associated with vaccine production and veterinary services pose a major challenge for market players. Furthermore, lack of standard practices for veterinary care in certain regions restrain the market growth. On the flip side, ongoing research & development activities for novel vaccines catering to multiple diseases present new opportunities. Rising awareness through social media marketing campaigns by key players also offers growth prospects for the market.

Key Features of the Study

This report provides in-depth analysis of the global dog vaccines market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global dog vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco Animal Health, Bayer Animal Health, Ceva Sante Animale, Virbac, Vetoquinol, Heska Corporation, Neogen Corporation, IDEXX Laboratories, Merial (Sanofi), Phibro Animal Health, Aratana Therapeutics, and Kemin Industries
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global dog vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dog vaccines market

Market Segmentation

Type of Vaccine Insights (Revenue, USD Bn, 2020 - 2032)
- Attenuated Live Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
- Others
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Canine Parvovirus
- Canine Distemper
- Canine Adenovirus
- Leptospirosis
- Bordetella
- Rabies
Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Injectable Vaccines
- Oral Vaccines
- Intranasal Vaccines
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Veterinary Clinics
- Animal Hospitals
- Home Care Settings
- Others
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Zoetis
- Merck Animal Health
- Boehringer Ingelheim
- Elanco Animal Health
- Bayer Animal Health
- Ceva Sante Animale
- Virbac
- Vetoquinol
- Heska Corporation
- Neogen Corporation
- IDEXX Laboratories
- Merial (Sanofi)
- Phibro Animal Health
- Aratana Therapeutics
- Kemin Industries

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Dogs Vaccines Market, By Type of Vaccine
- Global Dogs Vaccines Market, By Application
- Global Dogs Vaccines Market, By Route of Administration
- Global Dogs Vaccines Market, By End User
- Global Dogs Vaccines Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Dogs Vaccines Market, By Type of Vaccine, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Attenuated Live Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
Inactivated Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
Subunit Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
Toxoid Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
DNA Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
Recombinant Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)

5. Global Dogs Vaccines Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Canine Parvovirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
Canine Distemper
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
Canine Adenovirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
Leptospirosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
Bordetella
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
Rabies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)

6. Global Dogs Vaccines Market, By Route of Administration, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Injectable Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
Oral Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intranasal Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)

7. Global Dogs Vaccines Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Veterinary Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
Animal Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)

8. Global Dogs Vaccines Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type of Vaccine, 2021 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2021- 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type of Vaccine, 2021 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2021- 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021- 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2021- 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type of Vaccine, 2021 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2021- 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2021- 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type of Vaccine, 2021 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2021- 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2021- 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2021- 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type of Vaccine, 2021- 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type of Vaccine, 2021 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2021- 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Zoetis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck Animal Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boehringer Ingelheim
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Elanco Animal Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bayer Animal Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ceva Sante Animale
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Virbac
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Vetoquinol
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Heska Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Neogen Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
IDEXX Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merial (Sanofi)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Phibro Animal Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Aratana Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Kemin Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies